Release No 110 10 October 2003 Lundbeck and Teva announce European submission of rasagiline as a treatment for Parkinson's dis
TEVA REPORTS RECORD SALES AND NET INCOME IN Q2 • Net Sales reach $1.2 billion, Net Income $230 million, and EPS $0.35 • Sec
IVAX Corporation
Full Year 2010 Earnings
DEF 14A
ex99-2_008.jpg
Investor Relations Officer
DSM Investor Relations by DSM Group Business Services B.V.
Alvotech to Participate in Jefferies Healthcare Conference
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
Teva Investor Relations by Teva Pharmaceuticals USA, Inc.
Teva Pharmaceutical Industries Careers | Wellfound (formerly AngelList Talent)
Teva to Launch New Growth Strategy at Investor Day | Business Wire
Teva buying Cephalon for $6.8 billion - cleveland.com
Investor Relations Program
Elana Holzman - Head of Investor Relations - ZIM Integrated Shipping Services | LinkedIn
Teva Announces New Organization Structure and Leadership Changes | Business Wire
Teva: Great Investment With An Upside Even In Volatile Markets (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Industries Ltd. Protalix Ltd. Web Site: www.tevapharm.com Web Site: www.protalix.com
Teva's Great Dividend Yield (NYSE:TEVA) | Seeking Alpha
Website: www.tevapharm.com For Immediate Release Teva Reports 2007 Financials in XBRL Standard Intended to Facilitate Investor
DEF 14A
Website: www.tevapharm.com FOR IMMEDIATE RELEASE TEVA REPORTS FIRST QUARTER 2006 RESULTS Results include IVAX for the first tim
Teva to Launch New Growth Strategy at Investor Day
Teva Pharmaceutical Industries Ltd. SICOR Inc. Web Site: www.tevapharm.com www.sicor.com
Yael Ashman - Sr. Director, Investor Relations - Teva Pharmaceuticals | LinkedIn
Ex-Teva Chairman, Blockchain Investor Accused of Pump-and-Dump Scheme - WSJ
